Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myr (MYRG) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Myr (MYRG) over the last 16 years, with Q3 2025 value amounting to $76.2 million.

  • Myr's Cash & Equivalents rose 90688.33% to $76.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.2 million, marking a year-over-year increase of 90688.33%. This contributed to the annual value of $3.5 million for FY2024, which is 8608.78% down from last year.
  • Myr's Cash & Equivalents amounted to $76.2 million in Q3 2025, which was up 90688.33% from $23.0 million recorded in Q2 2025.
  • Myr's 5-year Cash & Equivalents high stood at $82.1 million for Q4 2021, and its period low was $1.9 million during Q2 2024.
  • In the last 5 years, Myr's Cash & Equivalents had a median value of $24.9 million in 2023 and averaged $35.6 million.
  • Per our database at Business Quant, Myr's Cash & Equivalents tumbled by 9182.06% in 2024 and then skyrocketed by 112825.04% in 2025.
  • Over the past 5 years, Myr's Cash & Equivalents (Quarter) stood at $82.1 million in 2021, then crashed by 37.83% to $51.0 million in 2022, then plummeted by 51.22% to $24.9 million in 2023, then tumbled by 86.09% to $3.5 million in 2024, then soared by 2100.09% to $76.2 million in 2025.
  • Its Cash & Equivalents stands at $76.2 million for Q3 2025, versus $23.0 million for Q2 2025 and $10.9 million for Q1 2025.